- Home
- ESP vs CTXR Comparison
ESP vs CTXR Comparison
Compare ESP & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- CTXR
- Stock Information
- Founded
- ESP 1928
- CTXR 2007
- Country
- ESP United States
- CTXR United States
- Employees
- ESP N/A
- CTXR N/A
- Industry
- ESP Industrial Machinery/Components
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- CTXR Health Care
- Exchange
- ESP Nasdaq
- CTXR Nasdaq
- Market Cap
- ESP 84.2M
- CTXR 84.9M
- IPO Year
- ESP N/A
- CTXR N/A
- Fundamental
- Price
- ESP $29.99
- CTXR $0.13
- Analyst Decision
- ESP
- CTXR Buy
- Analyst Count
- ESP 0
- CTXR 2
- Target Price
- ESP N/A
- CTXR $4.00
- AVG Volume (30 Days)
- ESP 37.1K
- CTXR 3.9M
- Earning Date
- ESP 11-13-2024
- CTXR 12-27-2024
- Dividend Yield
- ESP 3.39%
- CTXR N/A
- EPS Growth
- ESP 51.69
- CTXR N/A
- EPS
- ESP 2.46
- CTXR N/A
- Revenue
- ESP $40,611,323.00
- CTXR N/A
- Revenue This Year
- ESP N/A
- CTXR N/A
- Revenue Next Year
- ESP N/A
- CTXR N/A
- P/E Ratio
- ESP $12.00
- CTXR N/A
- Revenue Growth
- ESP 14.32
- CTXR N/A
- 52 Week Low
- ESP $16.50
- CTXR $0.11
- 52 Week High
- ESP $33.00
- CTXR $1.07
- Technical
- Relative Strength Index (RSI)
- ESP 48.03
- CTXR 26.57
- Support Level
- ESP $28.30
- CTXR $0.19
- Resistance Level
- ESP $31.86
- CTXR $0.51
- Average True Range (ATR)
- ESP 1.72
- CTXR 0.06
- MACD
- ESP -0.37
- CTXR -0.02
- Stochastic Oscillator
- ESP 47.47
- CTXR 5.98
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.